A Multicenter, Randomized, Double blind, Vehicle-controlled, Phase 2 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell C
Clinical Trial Grant
Administered By
Dermatology
Awarded By
PellePharm
Start Date
February 10, 2020
End Date
July 12, 2022
Administered By
Dermatology
Awarded By
PellePharm
Start Date
February 10, 2020
End Date
July 12, 2022